Abediterol
Abediterol (pronounced: ah-be-dit-er-ol) is a long-acting beta-adrenoceptor agonist (LABA) that is currently under development for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Etymology
The term "Abediterol" is derived from the combination of the words "beta", referring to the beta-adrenoceptor it targets, and "terol", a common suffix for bronchodilators.
Pharmacology
Abediterol works by stimulating the beta-2 adrenoceptors in the lungs, which causes the muscles in the airways to relax. This helps to open up the airways and makes it easier for air to get in and out of the lungs.
Clinical Trials
Abediterol has been studied in several clinical trials for its efficacy and safety in treating asthma and COPD. The results have shown that it is effective in improving lung function and reducing symptoms in patients with these conditions.
Related Terms
- Beta-2 adrenoceptor: A type of receptor found in the lungs that abediterol targets to produce its effects.
- Bronchodilator: A type of medication that relaxes and opens up the airways in the lungs, making it easier to breathe.
- Asthma: A chronic condition that causes inflammation and narrowing of the airways, leading to difficulty breathing.
- Chronic obstructive pulmonary disease: A group of lung diseases that block airflow and make it difficult to breathe.
See Also
External links
- Medical encyclopedia article on Abediterol
- Wikipedia's article - Abediterol
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski